Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G
Titel:
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G
Auteur:
Owonikoko, Taofeek K. Redman, Mary W. Byers, Lauren A. Hirsch, Fred R. Mack, Philip C. Schwartz, Lawrence H. Bradley, Jeffrey D. Stinchcombe, Thomas E. Leighl, Natasha B. Al Baghdadi, Tareq Lara Jr., Primo Miao, Jieling Kelly, Karen Ramalingam, Suresh S. Herbst, Roy S. Papadimitrakopoulou, Vassiliki Gandara, David R.